Williams R J, Lindridge M A, Said A A, Livermore D M, Williams J D
J Antimicrob Chemother. 1984 Jul;14(1):9-16. doi: 10.1093/jac/14.1.9.
The antibiotic susceptibility of 1866 consecutive non-replicate clinical isolates of Pseudomonas aeruginosa from 24 British hospitals was examined. Antibiotics tested and resistance breakpoints selected were: carbenicillin (MIC greater than 128 mg/l), azlocillin (greater than 32 mg/l), cefotaxime (greater than 16 mg/l), cefoperazone (greater than 16 mg/l), ceftazidime (greater than 16 mg/l), amikacin (greater than 4 mg/l) and gentamicin (greater than 2 mg/l). Resistance frequencies detected were: carbenicillin 9.6%, azlocillin 3.9%, cefotaxime 19.0%, cefoperazone 4.3%, ceftazidime 0.3%, amikacin 3.8%, and gentamicin 5.5%.
对来自英国24家医院的1866株连续的非重复铜绿假单胞菌临床分离株进行了抗生素敏感性检测。所检测的抗生素及选择的耐药性断点为：羧苄西林（MIC大于128mg/L）、阿洛西林（大于32mg/L）、头孢噻肟（大于16mg/L）、头孢哌酮（大于16mg/L）、头孢他啶（大于16mg/L）、阿米卡星（大于4mg/L）和庆大霉素（大于2mg/L）。检测到的耐药频率为：羧苄西林9.6%、阿洛西林3.9%、头孢噻肟19.0%、头孢哌酮4.3%、头孢他啶0.3%、阿米卡星3.8%、庆大霉素5.5%。
